ABBVHealthcareLarge-Cap
AbbVie Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for AbbVie Inc. (ABBV), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are ABBV insiders buying or selling?
AbbVie Inc. insiders reported 16 open-market buys ($16.1M) and 98 sells ($631.5M) across 114 Form 4 filings — a net selling position of $615.4M.
Source: SEC EDGAR Form 4
Key Statistics (as of Mar 6, 2026)
Total Form 4 filings
114
SEC EDGAR
Insider filers
21
Insider buys (16)
$16.1M
Insider sells (98)
$631.5M
Insider sentiment
Net sellingNet insider flow of $615.4M in net selling.
Recent ABBV insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 6, 2026 | David Ryan Purdue | SVP, Controller | Sale | 5.2K | $233.56 | $1.2M |
| Mar 3, 2026 | Perry C Siatis | EVP, GC AND SECRETARY | Sale | 18.7K | $234.39 | $4.4M |
| Feb 27, 2026 | Perry C Siatis | EVP, GC AND SECRETARY | Sale | 22.4K | $230.00 | $5.1M |
| Aug 14, 2025 | Azita Saleki-Gerhardt | EVP, CHIEF OPERATIONS OFFICER | Sale | 42.4K | $198.42 | $8.4M |
| Aug 7, 2025 | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Sale | 13.3K | $198.51 | $2.6M |
| Apr 2, 2025 | Jeffrey Ryan Stewart | EVP, CHIEF COMMERCIAL OFFICER | Sale | 58.8K | $210.08 | $12.4M |
| Mar 18, 2025 | Scott T Reents | EVP, CHIEF FINANCIAL OFFICER | Sale | 17.6K | $212.34 | $3.7M |
| Mar 4, 2025 | Richard A Gonzalez | Director | Sale | 98.6K | $205.45 | $20.3M |
| Mar 4, 2025 | Perry C Siatis | EVP, GC AND SECRETARY | Sale | 27.9K | $208.69 | $5.8M |
| Mar 4, 2025 | Timothy J. Richmond | EVP, CHIEF HR OFFICER | Sale | 21.3K | $210.45 | $4.5M |
| Feb 28, 2025 | Kevin K Buckbee | SVP, CONTROLLER | Sale | 18.9K | $203.41 | $3.9M |
| Feb 28, 2025 | Timothy J. Richmond | EVP, CHIEF HR OFFICER | Sale | 29.9K | $202.90 | $6.1M |
| Feb 24, 2025 | Perry C Siatis | EVP, GC AND SECRETARY | Sale | 5.8K | $197.90 | $1.1M |
| Dec 18, 2024 | Kevin K Buckbee | SVP, CONTROLLER | Sale | 1.8K | $172.24 | $310.0K |
| Aug 7, 2024 | Richard A Gonzalez | EXECUTIVE CHAIRMAN OF BOARD | Sale | 66.5K | $186.52 | $12.4M |
| Jul 19, 2024 | Richard A Gonzalez | EXECUTIVE CHAIRMAN OF BOARD | Sale | 282.8K | $175.00 | $49.5M |
| Mar 22, 2024 | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Sale | 21.1K | $176.30 | $3.7M |
| Mar 20, 2024 | Jeffrey Ryan Stewart | EVP, CHIEF COMMERCIAL OFFICER | Sale | 58.9K | $178.79 | $10.5M |
| Mar 5, 2024 | Timothy J. Richmond | EVP, CHIEF HR OFFICER | Sale | 75.7K | $177.27 | $13.4M |
| Mar 1, 2024 | Scott T Reents | EVP, CHIEF FINANCIAL OFFICER | Sale | 14.1K | $177.44 | $2.5M |
| Mar 1, 2024 | Kevin K Buckbee | SVP, CONTROLLER | Sale | 5.1K | $176.65 | $908.7K |
| Mar 1, 2024 | Robert A. Michael | PRES & CHIEF OPERATING OFFICER | Sale | 68.9K | $176.45 | $12.2M |
| Mar 1, 2024 | Perry C Siatis | EVP, GC AND SECRETARY | Sale | 9.9K | $177.39 | $1.8M |
| Mar 1, 2024 | Richard A Gonzalez | CHAIRMAN OF THE BOARD AND CEO | Sale | 138.6K | $177.27 | $24.6M |
| Feb 27, 2024 | Perry C Siatis | EVP, GC AND SECRETARY | Sale | 13.8K | $177.51 | $2.4M |
Showing the 25 most recent of 114 Form 4 filings for AbbVie Inc..
Most active ABBV insiders
- Timothy J. Richmond12 filings
- Elaine K. Sorg10 filings
- Jeffrey Ryan Stewart10 filings
- Azita Saleki-Gerhardt9 filings
- Perry C Siatis9 filings
Ask anything about ABBV insider activity
Use Trabud's AI agent to query AbbVie Inc.'s Form 4 history in plain English — "Show me ABBV CEO purchases this year" or compare it against any other ticker.
Open the AI agentABBV insider trading FAQ
Are AbbVie Inc. insiders buying or selling?
Across 114 SEC Form 4 filings, AbbVie Inc. (ABBV) insiders reported 16 open-market purchases totaling $16.1M and 98 sales totaling $631.5M. That is a net selling position of $615.4M.
How many insiders trade ABBV stock?
21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for AbbVie Inc.. The most recent filing was accepted on Mar 6, 2026.
Where does Trabud get ABBV insider trading data?
All ABBV insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.